AGP Executive Report

Medicaid Shake-Up: Trump’s administration is ending federal Medicaid funding for gender-affirming care for minors, with advocates warning of major access losses as rules roll out this fall. Work Requirements Pressure: Massachusetts launched a $10M campaign to help residents navigate new Medicaid work and eligibility hurdles, after officials warned hundreds of thousands could lose coverage. Coverage Risk Beyond Gender Care: Advocates also say new Medicaid work rules could jeopardize people with cancer or HIV, while states prepare outreach for “tough new” rules. Vaccines Under Fire: Trump signed an order reducing recommended childhood vaccines and separating MMR into single shots; major medical groups call it dangerous and point to measles risk. Health Tech & Devices: Pro Medicus won a 7-year, $23M cloud imaging contract with St. Luke’s Health System, and Vitruvian Health completed Bradley County’s first atrial leadless pacemaker implantation. Hospital Expansion: Geisinger Wyoming Valley topped off an 11-story acute care tower adding private rooms, ER capacity, hybrid ORs, and ICU beds. Pharma & Policy: Glenmark’s US unit agreed to pay $15.28M to settle generic drug antitrust claims with Humana. Clinical Research: Actinogen Medical is advancing its oral Alzheimer’s drug Xanamem toward a pivotal readout expected in Nov 2026.

Diabetes Care: Novo Nordisk launched Awiqli, the first once-weekly basal insulin for adults with type 2 diabetes, aiming to boost adherence with broad U.S. pharmacy availability. Drug Safety: The FDA announced a nationwide recall of Diovan (valsartan) tablets after failed dissolution testing, raising short-term, reversible risk concerns. Medicare & Costs: New Medicare Part D “Extra Help” (LIS) guidance highlights who qualifies as the Part D out-of-pocket cap rises to $2,100 in 2026. Policy Shock: New Medicare joint replacement rules (CJR-X) take effect in 2028, and orthopedic firms say they’re largely unfazed by potential implant payment changes. Medication Access Tech: LiviPod unveiled a modular, subscription-free pill dispenser paired with a free app for reminders and caregiver monitoring. Healthcare Systems: A Greek recall of Remedica generics is forcing doctors and pharmacies to scramble over substitutions and prescription changes. Public Health & Equity: India sent 8 metric tonnes of essential medicines to Bolivia to support public healthcare. Clinical Research & Wellness: Studies continue to test amla (Indian gooseberry) for cholesterol and blood sugar control, positioning it as a low-risk, researched supplement. Local Health News: A medical incident on York Minster’s roof prompted air ambulance response and cordons while the visitor received care. EMS Funding: Minnesota’s Cottage Grove voted to end EMS service for neighboring cities unless state approval and coverage changes are made.

CAR-T Deal: Hemogenyx signed a definitive collaboration with Cellin Technologies to manufacture and implement its HG-CT-1 CAR-T for relapsed/refractory AML in Estonia under the hospital exemption pathway. Whole-Body MRI Backlash: Radiologists and other clinicians criticized neuroscientist podcaster Andrew Huberman’s push for whole-body MRI screening in healthy people, citing lack of recommendations and risks from false positives. Radiation Safety Support: UAB researchers are building TheraGuide, a digital tool to help patients follow radiation safety precautions after radiopharmaceutical therapy. Vaccine Policy Fight: Trump’s executive order urges fewer childhood vaccines and separate MMR shots, drawing medical concern and criticism from health officials. TB Medicine Shortages: In the Philippines, MSF says recurring TB drug stock-outs are forcing patients to buy medicines privately, raising costs and risking resistance. Pharma Legal Fallout: Veloxis Pharmaceuticals will resolve U.S. kickback allegations tied to Envarsus XR with a deferred prosecution agreement and $46M+ payment. Medical Devices Law Push: India’s medtech groups want a standalone medical device law, arguing a draft bill is too pharma-focused. Healthcare Access Gaps: Rangpur Medical College Hospital in Bangladesh faces an ICU bed shortage, with critical patients waiting for limited capacity. Public Health in War: WHO says a Dnipro humanitarian medical warehouse was destroyed in strikes, wiping supplies meant for hundreds of thousands. Rural Training Recognition: Australia’s rural generalist training programs gained accreditation, setting a pathway toward specialist recognition.

Medicare & Costs: Original Medicare has no out-of-pocket cap, so many seniors consider Medigap for financial protection—timing matters when you turn 65. Medicare Advantage Cuts: Extra perks in Medicare Advantage (like OTC, meals, rides, and fitness) are being scaled back as insurers face tighter payments and rising costs. 340B Legal Win: A U.S. court upheld South Dakota’s rule limiting manufacturers’ control over how discounted 340B drugs reach local providers, aiming to protect access for underserved communities. Manufacturing Investment: Bristol Myers Squibb will build a $2.3B, multi-modality manufacturing campus near Houston, creating nearly 500 jobs. Pharma Dealmaking: Jazz Pharmaceuticals agreed to buy Actio Biosciences for up to about $1.32B to expand its rare epilepsy pipeline. Access to Birth Control: Manitoba expanded pharmacists’ scope so trained pharmacists can assess, prescribe, and administer eligible birth control. Mental Health in the Spotlight: Simone Biles shared she travels with emergency anxiety medication, keeping the conversation on managing mental health practical. Public Health & Safety: Back-to-school guidance from Nebraska Medicine and local pediatricians emphasizes sleep routines, screen limits, and hand hygiene. Clinical Trials: A VA site in Tuscaloosa is set to run a psilocybin trial for treatment-resistant depression. Infectious Disease Watch: Global health coverage highlights ongoing Ebola and mpox risks and the need for preparedness before outbreaks surge.

Biotech Deal: Innate Pharma and Sobi struck a strategic partnership to license lacutamab and enable the TELLOMAK-3 confirmatory Phase 3 study in cutaneous T-cell lymphoma, a key step toward accelerated approval in Sézary syndrome. Ophthalmology & Access: A Medicare analysis found anti-VEGF drug use varies between fee-for-service and Medicare Advantage plans, with aflibercept leading in FFS and bevacizumab in MA. New Eye Products: Harrow relaunched Byooviz, a ranibizumab biosimilar, and Nicox’s China partner Ocumension filed an NDA for NCX 470 to lower intraocular pressure in open-angle glaucoma. Policy & Safety: Cairo pharmacists urged clearer, legible prescriptions and wider electronic prescribing to cut medication errors. Global Health Workforce: Kyrgyzstan plans to staff medical points and a mobile hospital for the VI World Nomad Games, using 600+ specialists. Health Systems & Medicines: Zimbabwe’s local pharma lobby warned public procurement is too low for domestic manufacturers to scale. Politics & Care: Malaysia’s PM Anwar Ibrahim is undergoing medical tests and procedures and will be observed for two days.

Medicare Drug Costs: The Trump administration plans to end the Medicare Part D subsidy program in 2027, with experts warning prescription prices could rise most for people on original Medicare plus Medigap. Public Health—Hepatitis B: Jamaica’s health officer urged Hepatitis B vaccination and safer sex, noting the virus can survive outside the body for up to a week and can lead to liver cancer. Global Aid—Medicines Shipped: India sent 8 metric tonnes of life-saving medicines to Bolivia to support public healthcare capacity. Health Access & Safety Nets: AARP says expanding Medicare’s drug price negotiation using Most-Favored-Nation pricing could cut Medicare spending by nearly $200B over five years. Clinical Research: A phase 3 trial reported brepocitinib improved dermatomyositis outcomes at 52 weeks, though serious infections were more common than with placebo. Healthcare Under Fire: Russia destroyed a WHO medical warehouse in Dnipro, disrupting emergency supplies for frontline facilities. Medical Tragedy: Andhra’s Priyanka, a postgraduate medical student injured in a drunk hit-and-run, died in Hyderabad after being declared brain dead. Medication & Lifestyle: Experts promoted balanced salads as a sustainable lunch habit, and a study linked living near dry cleaners with higher Parkinson’s odds.

Supreme Court on hospital care: India’s top court ordered two Ghaziabad private hospitals to pay compensation after a four-year-old rape victim was denied timely medical care and died, and it signaled it will set broader guidelines for handling sexual-assault and medical emergencies. Data-breach probe: The Supreme Court issued notice on a plea seeking a CBI investigation into an alleged large-scale cyberattack and medical data breach affecting nearly 200,000 Indians. Drug safety recalls: Australia recalled a children’s throat lozenge (Key-Sun Kids Honey & Eucalyptus and Acerola) after metal fragments were found in batch 0072; parents are urged not to use it. Public health operations: Kyrgyzstan plans medical support for 600+ workers, mobile units, and a temporary hospital for the SCO Summit and World Nomad Games. Regional health cooperation: Bahrain backed GCC efforts to strengthen healthcare cooperation and pharmaceutical security, including unified procurement to protect medicine supply. Care access under pressure: West Bengal ordered a two-minute silence for “Abhaya” on the second anniversary of the RG Kar trainee doctor case.

FDA Approval: FDA approved Takeda’s Orzeyful (oveporexton), the first medicine designed to treat the full symptom range of narcolepsy type 1 by targeting orexin signaling. Diabetes Care Access: New Zealand’s Pharmac will expand funding for four type 2 diabetes medicines (including empagliflozin and GLP-1 options) to reach 30,000+ more people by removing several eligibility barriers. Hospital Capacity Boost: Odisha approved 152 new posts across 10 government medical colleges to strengthen super-specialty departments like cardiology, neurology, neurosurgery, nephrology, and surgical gastroenterology. Public Health & Training: Malaysia’s lifestyle medicine group urged structured training for clinicians to help prevent and manage type 2 diabetes, including remission-focused lifestyle programs when appropriate. Medication Safety: American Regent issued a nationwide recall of certain Adequan dog and horse injections after glass fibers were found in vials. Healthcare in Conflict: Gaza’s Hind Al-Daghma dialysis center reported severe shortages and unprecedented pressure, warning that limited supplies are forcing life-or-death compromises for 200+ patients. Medicare Costs Explained: A Q&A clarified that Medicare Part B premiums aren’t a percentage of Social Security benefits, with higher costs possible via IRMAA.

Medico-legal Fallout (India): In Rajamahendravaram, a student hit-and-run allegedly driven by a drunk driver has left Priyanka declared brain dead, while Andhra’s CM Naidu orders strict action and “zero tolerance,” as police hold two suspects in custody. Drug Quality Crackdown (India): Maharashtra FDA permanently cancels Pune-based InduCare Pharma’s license after six Ayurvedic medicines failed quality tests and inspectors found contamination plus major GMP lapses. Workforce Boost (India): Himachal Pradesh appoints 259 assistant staff nurses for government medical colleges and AIMSS Chamiana to strengthen patient care. Pharma & AI (Global): A report says AI is now a core capability in pharma R&D, speeding target discovery and shaping investment and development decisions. Medication Safety (US): Medicare will require hospitals to capture unique device identifiers for implantable devices, aiming to improve recall tracking. Access & Equity (Canada): Manitoba expands pharmacists’ ability to prescribe birth control, with doctors calling for clearer follow-up responsibilities. Waste & Cost (UK): England’s wasted medicines—estimated at 3,400 tonnes—could fill 75 swimming pools and cost the NHS at least £480m a year.

Medicaid Work Rules: Allegheny County warns that 2027 Medicaid requirements could kick ~26,000 people off coverage due to added documentation barriers—even when they’re otherwise eligible. Legal Fight Over Doctor Speech: A federal judge blocked California medical boards from punishing three physicians for COVID-19 advice, ruling regulators can’t target viewpoint. Medical Leave in Politics: Philippines Sen. Loren Legarda confirmed a formal medical leave Aug. 3–5 after reports she traveled abroad, urging the public not to link it to “false and baseless” allegations. Autism Care Outreach: Delta Gov. Oborevwori’s wife expanded free medical support for families of children with autism, reaching 520+ beneficiaries with care, meds, and assistive devices. Drug Quality & Safety: Andhra Pradesh health officials pushed “zero tolerance” for poor-quality medicines, while Nigeria’s NAFDAC warned of suspected counterfeit asthma medicine circulating in markets. Healthcare Access & Costs: A study found Medicare DXA scans fell 35% since 2005–2023, with the steepest drops among Hispanic, Black, and disadvantaged groups. Hospital Operations: MU Health Care’s South Providence building will close through the weekend for an air-conditioning issue, shifting some visits to telehealth. Fraud Case: Michigan charged a woman with Medicaid fraud over alleged unpaid caretaking that left an elderly disabled man severely neglected.

Regulation Overhaul: India is drafting a new Drugs, Medical Devices and Cosmetics Bill (2026) to replace the 1940 law, aiming to modernize oversight, expand the DCGI’s powers, and crack down on substandard medicines. AI Drug Discovery: Insilico Medicine says generative AI can speed early drug development, but its focus now is making breakthroughs repeatable at industrial scale. Controlled Medicines Access: Qatar launched an electronic permit system for travellers to carry controlled medicines, listing allowed narcotic and psychotropic options with conditions. Medico-Legal Tangle: Pakistan’s Mir Raza Ali exhumation was postponed as his family challenges a reconstituted medical board. Patient Safety & Access: An Odisha woman died after an alleged wrong injection at a medicine store; police detained staff as an investigation begins. Care Delivery Tech: Cleveland Clinic started prescription drone delivery with Zipline for eligible patients (controlled substances excluded for now). Policy & Fraud: Kentucky joined a 17-state push for the STOP FRAUD in Medicaid Act to expand recipient-fraud enforcement powers. Clinical Care Advance: Cheyenne Regional Medical Center performed Wyoming’s first Amulet procedures for atrial fibrillation, offering an alternative to long-term blood thinners.

Medicare Drug Costs: CMS will end the Medicare Part D Premium Stabilization Demonstration at the end of 2026, with many beneficiaries facing higher 2027 premiums and critics warning about affordability. Medicaid Pressure: A new study projects nearly 500,000 Medicaid enrollees with diabetes could lose coverage by 2034, hitting rural patients hardest. Medicaid Enforcement: Minnesota approved tougher sentencing for Medicaid fraud cases over $1M, with presumptive prison terms. Pharma Oversight: India’s FDA permanently cancelled Inducare Pharma’s ayurvedic manufacturing license after alleged GMP and Drugs & Cosmetics Act violations. Public Health & Access: LECOM Health opened a new Colonial Family Pharmacy in Greene Township to reduce travel for prescriptions. Policy & Work Leave: The Trump administration expanded the employer tax credit for paid family and medical leave via IRS/Treasury guidance. Care in the Field: The UAE inspected a 100-bed floating Level III trauma hospital aimed at disaster and crisis response. Clinical Innovation: Assort Health named Sunny Eappen, MD, MBA, as Chief Medical Officer to guide enterprise AI agents for patient access and care pathways.

Emergency Care Access: Kenya’s President Ruto launched the SHA 922 Lifeline and a national ambulance dispatch centre, creating a single free emergency number (922) that routes callers to nearby ambulances and the right facility. Health System Quality: U.S. News & World Report named United Hospital Center and multiple WVU Medicine hospitals “High Performing” across major procedures and conditions, highlighting stroke, heart, cancer, and orthopedic care. Clinical Research & Innovation: Actinogen Medical outlined its Alzheimer’s drug Xanamem, an oral cortisol-control candidate, with a first pivotal trial expected in November 2026. Pharma Manufacturing: Gland Pharma and Neuland Labs announced a long-term CDMO partnership to expand sterile API manufacturing for complex depot and sterile products. Public Health Integrity: Odisha’s government panel began investigating alleged circulation of a medical PG exam question paper at MKCG Medical College, reviewing CCTV and exam-hall records. Women’s Health: A Canada clinic launched a physician-led women’s health and longevity program focused on perimenopause, menopause, and metabolic wellness. Care Delivery Tech: Pacto Medical’s compact prefilled syringe concept Slimshot won a Red Dot Design Concept award.

Rural Pharmacy Access: A new Emplify Health by Gundersen pharmacy opened in Hillsboro, Wisconsin, aiming to cut travel time for about 5,000 residents. Medicaid Fraud Crackdown: Alaska prosecutors indicted Kyle and Molly Bates and others over alleged Medicaid fraud tied to group homes, including claims of billed services not provided or improperly documented. End-of-Life Policy: New York’s Medical Aid in Dying law took effect statewide, adding safeguards like physician assessments, a mental health evaluation, and a waiting period. Controlled Medicines for Travelers: Qatar’s MoPH launched an electronic permit system for travelers carrying controlled medicines, with approvals typically within three working days. Pediatric Care Access: UR Medicine is rolling out a pediatric mobile clinic to bring routine visits and vaccines directly to neighborhoods, regardless of insurance. Healthcare Costs: IRS/Treasury issued guidance on the permanent expansion of the employer paid family and medical leave tax credit. Clinical Leadership: Dartmouth’s Geisel School of Medicine welcomed Jennifer Hunt as dean, starting with incoming MD and MPH students. Public Health & Safety: A crash in East Liverpool closed Route 30, and a man was sought after threatening to blow up an Ocean Springs medical clinic.

Cancer & Safety Watch: WHO/IARC classified hydrochlorothiazide, voriconazole, and tacrolimus as Group 1 carcinogens, but experts stress patients shouldn’t stop meds without a clinician. Uro-oncology Updates: At ASCO, researchers discussed molecular shifts in residual bladder cancer after neoadjuvant therapy, alongside long-term survival signals for EV/pembrolizumab in metastatic disease. Drug Access & Policy: Philippines expanded VAT-exempt medicines to 2,277 items; in the US, Medicaid fraud enforcement in Pennsylvania targeted home-care billing schemes. Regulation & Quality: Sri Lanka fined two medical institutions for expired medicines and overcharging; Nepal appointed Dr. Kadir Alam to lead the Pharmacy Council. Global Health Supply: Sudan imported $274M in medicines in H1 2026 as availability rose but prices and shortages persist. Care Delivery: West Virginia and southern Pennsylvania pharmacies are partnering with heart failure specialists to support rural patients between visits. Tech & Rights: A debate is growing over AI medical scribes and whether patients can refuse them without losing care.

Medicaid Fraud Crackdown: DOJ charged 19 defendants in a $4M Philadelphia Medicare/Medicaid scheme, with additional cases alleging home health aides and Medicaid patients billed for services not provided. State Accountability: Missouri AG Catherine Hanaway won a Medicaid fraud conviction over false PCA time records, while other states push tougher federal authority to target beneficiary fraud. AI Governance: The Federation of State Medical Boards says generative AI shouldn’t be licensed like a physician, arguing it must be governed through existing accountability structures. FDA Peptides: An FDA advisory committee backed loosening “gray market” peptide regulation, despite safety concerns and backlash over industry ties. Medicare Policy: CMS proposes ending Medicare payment for outsourced remote monitoring unless delivered by employed clinical staff, with added billing guardrails. Maternal Care at Home: Sidra Medicine launched private midwifery home visits for postnatal care. Rural Cardiology Support: A pharmacist-linked program connects community pharmacies with heart failure specialists in West Virginia and southern Pennsylvania. Healthcare Access & Equity: Pakistan faces a doctor training bottleneck as postgraduate slots lag behind medical graduates.